Abstract:The tripartite motif (TRIM) family of E3 ubiquitin ligases is well known for its roles in antiviral restriction and innate immunity regulation, in addition to many other cellular pathways. In particular, TRIM25-mediated ubiquitination affects both carcinogenesis and antiviral response. While individual substrates have been identified for TRIM25, it remains unclear how it regulates diverse processes. Here we characterized a mutation, R54P, critical for TRIM25 catalytic activity, which we successfully utilized to "trap" substrates. We demonstrated that TRIM25 targets proteins implicated in stress granule formation (G3BP1/2), nonsense-mediated mRNA decay (UPF1), nucleoside synthesis (NME1), and mRNA translation and stability (PABPC4). The R54P mutation abolishes TRIM25 inhibition of alphaviruses independently of the host interferon response, suggesting that this antiviral effect is a direct consequence of ubiquitination. Consistent with that, we observed diminished antiviral activity upon knockdown of several TRIM25-R54P specific interactors including NME1 and PABPC4. Our findings highlight that multiple substrates mediate the cellular and antiviral activities of TRIM25, illustrating the multi-faceted role of this ubiquitination network in modulating diverse biological processes. Ubiquitin E3 ligases each interact with and ubiquitinate a subset of cellular proteins, thereby regulating specific cellular processes. Tripartite motif containing protein 25 (TRIM25) is one such E3 ligase involved in carcinogenesis and antiviral innate immunity. TRIM25 catalytic activity is indispensable for the host antiviral response against alphaviruses, an arthropod-borne group of RNA viruses possessing expanding distributions and pandemic potential. However, it remains poorly understood which TRIM25 substrates mediate viral inhibition. To complicate the matter, identification of E3 ligase substrates is technically challenging, given the transient nature of ligase-substrate interactions. Here, we present the first comprehensive ubiquitinome study utilizing a novel "substrate-trapping" approach to identify TRIM25 target proteins. We found that TRIM25 ubiquitinates key players in translational and nucleic acid metabolic processes, specifically involving stress granule formation, nonsense-mediated mRNA decay, nucleotide synthesis, and translation initiation. In addition, TRIM25 ligase activity is critical for its inhibition of diverse alphaviruses through viral translation suppression, highlighting the importance of ubiquitination in driving antiviral activity in this context. Our study both provides new insights into understanding the innate immune and cell biology roles of TRIM25 and paves the way forward for identification of novel TRIM substrates at large.

Functional Analysis on the Anti-Hiv Activity of TRIM5α

Retroviral Restriction Factors Trim5 Alpha: Therapeutic Strategy To Inhibit Hiv-1 Replication

An all-atom view into the disordered interaction interface of the TRIM5α PRYSPRY domain and the HIV capsid

TRIM5α Modulates Immunodeficiency Virus Control in Rhesus Monkeys

Association of TRIM22 with the Type 1 Interferon Response During Primary Human Cytomegalovirus Infection in THP-1 Macrophages

The effect of innate antiviral factor TRIM5α on Hepatitis B virus replication

The control of viral infection by tripartite motif proteins and cyclophilin A

TRIM5α polymorphism identification in cynomolgus macaques of Vietnamese origin and Chinese rhesus macaques

The cyclophilin A-binding loop of the capsid regulates the human TRIM5α sensitivity of nonpandemic HIV-1

TRIM5α: A Protean Architect of Viral Recognition and Innate Immunity

Trim5 Alpha H43y Polymorphism And Susceptibility To Hiv-1 Infection: A Meta-Analysis

Targeting the rhesus macaque TRIM5α gene to enhance the susceptibility of CD4 + T cells to HIV-1 infection

Characterization of a Core Fragment of the Rhesus Monkey TRIM5α Protein

TRIM5 alpha Drives SIVsmm Evolution in Rhesus Macaques

Role of SUMO-1 and SUMO interacting motifs in rhesus TRIM5α-mediated restriction

Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1

TRIM5α recruits HDAC1 to p50 and Sp1 and promotes H3K9 deacetylation at the HIV-1 LTR

Novel Recombinant Engineered Gp41 N-terminal Heptad Repeat Trimers and Their Potential As Anti-Hiv-1 Therapeutics or Microbicides.

Elucidation of TRIM25 ubiquitination targets involved in diverse cellular and antiviral processes

Structure-Function Study and Anti-Hiv Activity of Synthetic Peptide Analogues Derived from Viral Chemokine Vmip-Ii

Inhibition of the TRIM24 bromodomain reactivates latent HIV-1